NM_006892.4(DNMT3B):c.14C>G (p.Thr5Ser) AND Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 30, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001347697.6

Allele description [Variation Report for NM_006892.4(DNMT3B):c.14C>G (p.Thr5Ser)]

NM_006892.4(DNMT3B):c.14C>G (p.Thr5Ser)

Gene:

DNMT3B:DNA methyltransferase 3 beta [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

20q11.21

Genomic location:

Preferred name:

NM_006892.4(DNMT3B):c.14C>G (p.Thr5Ser)

HGVS:

NC_000020.11:g.32780337C>G
NG_007290.1:g.22953C>G
NM_001207055.2:c.14C>G
NM_001207056.2:c.14C>G
NM_006892.4:c.14C>GMANE SELECT
NM_175848.2:c.14C>G
NM_175849.2:c.14C>G
NM_175850.3:c.50C>G
NP_001193984.1:p.Thr5Ser
NP_001193985.1:p.Thr5Ser
NP_008823.1:p.Thr5Ser
NP_787044.1:p.Thr5Ser
NP_787045.1:p.Thr5Ser
NP_787046.1:p.Thr17Ser
LRG_56:g.22953C>G
NC_000020.10:g.31368143C>G

Protein change:

T17S

Links:

dbSNP: rs201455430

NCBI 1000 Genomes Browser:

rs201455430

Molecular consequence:

NM_001207055.2:c.14C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001207056.2:c.14C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_006892.4:c.14C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_175848.2:c.14C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_175849.2:c.14C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_175850.3:c.50C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency (ICF1)
Synonyms:: ICF syndrome; Immunodeficiency syndrome, variable; Centromeric instability, immunodeficiency syndrome; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0000133; MedGen: C0398788; OMIM: PS242860

Recent activity

Clear Turn Off Turn On

ERP039584 (72)
SRA

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001541970	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Aug 30, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001541970

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Aug 30, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001541970.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces threonine with serine at codon 5 of the DNMT3B protein (p.Thr5Ser). The threonine residue is weakly conserved and there is a small physicochemical difference between threonine and serine. This variant is present in population databases (rs201455430, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with DNMT3B-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine